Collate Secures $95 Million in Latest Series A Funding Round

Collate secured $95 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Collate Raises $95 million in Funding

Collate is a a San Francisco, CA-based Digital Health company focused on Expand AI Platform For Regulated Life Sciences Workflows.

Investors Behind the Funding

The round was backed by Redpoint Ventures. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Collate operates in Healthcare & Life Sciences. Collate's Series A round shows investors are still backing digital health platforms with real scale narratives. At $95M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Expand AI Platform For Regulated Life Sciences Workflows

Looking Ahead

Collate Raises $95 Million Series A To Expand AI Platform For Regulated Life Sciences Workflows

Source reference: original announcement/article.